The most important financial indicators for the company Pure Pharmaceuticals Srl - Unique Identification Number 30444820:
sales in 2023 was
-
euro, registering a net profit of
-124
euro and having an average number of
employees.
Firma isi desfasoara activitatea in domeniul Fabricarea preparatelor farmaceutice having the NACE code 2120.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Pure Pharmaceuticals Srl - CUI 30444820
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
0
0
0
0
0
0
0
0
0
0
Current Assets
8.275
8.280
8.063
7.909
7.095
6.958
6.557
10.967
10.880
10.723
Inventories
0
0
18
0
0
0
0
0
0
0
Receivables
778
798
790
776
0
0
0
4.677
4.691
4.677
Cash
7.497
7.482
7.255
7.132
7.095
6.958
6.557
6.290
6.188
6.045
Shareholders Funds
-3.432
-3.593
-3.771
-3.747
-4.350
-4.265
-4.453
63
133
8
Social Capital
45
45
45
44
43
42
41
40
41
40
Debts
11.707
11.872
11.834
11.655
11.445
11.223
11.010
10.904
10.747
10.714
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"2120 - 2120"
CAEN Financial Year
2120
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
10.723 euro in 2023 which includes Inventories of
0 euro, Receivables of
4.677 euro and cash availability of
6.045 euro.
The company's Equity was valued at
8 euro, while total Liabilities amounted to
10.714 euro.
Equity decreased by -124 euro, from 133 euro in 2022, to 8 in 2023.
Activate a subscription with unlimited access and get contact details for any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Recurring
- monthly payment
Pay
25,21EUR / month
NELIMITAT
Reports that can be accessed based on the subscription:
✔ Financial Rating
✔ Payment Limits
✔ Outstanding Debts
✔ Probability of Insolvency
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
